| 000 | 01885 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517022920.0 | ||
| 264 | 0 | _c20160104 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1879-1484 | ||
| 024 | 7 |
_a10.1016/j.atherosclerosis.2015.03.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLu, Zhongyang | |
| 245 | 0 | 0 |
_aGPR40/FFA1 and neutral sphingomyelinase are involved in palmitate-boosted inflammatory response of microvascular endothelial cells to LPS. _h[electronic resource] |
| 260 |
_bAtherosclerosis _cMay 2015 |
||
| 300 |
_a163-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 |
_aInflammation _xenzymology |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-6 _xgenetics |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMicrovessels _xdrug effects |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xgenetics |
| 650 | 0 | 4 |
_aPalmitic Acid _xpharmacology |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSphingomyelin Phosphodiesterase _xgenetics |
| 650 | 0 | 4 |
_aSphingomyelins _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aLi, Yanchun | |
| 700 | 1 | _aJin, Junfei | |
| 700 | 1 | _aZhang, Xiaoming | |
| 700 | 1 | _aHannun, Yusuf A | |
| 700 | 1 | _aHuang, Yan | |
| 773 | 0 |
_tAtherosclerosis _gvol. 240 _gno. 1 _gp. 163-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.atherosclerosis.2015.03.013 _zAvailable from publisher's website |
| 999 |
_c24729254 _d24729254 |
||